Teaching Body

Image
Prof. Masayuki Inoue, University of Tokyo (Japan)
Masayuki Inoue received a B.Sc. degree in Chemistry from the University of Tokyo in 1993. In 1998, he obtained his Ph.D. from the same university, working under the supervision of Prof. Kazuo Tachibana. After spending two years with Prof. Samuel J. Danishefsky at the Sloan-Kettering Institute for Cancer Research (1998-2000), he joined the Graduate School of Science at Tohoku University as an assistant professor in the research group of Prof. Masahiro Hirama. At Tohoku University, he was promoted to lecturer in 2003 and then to associate professor in 2004. In 2007, he moved to the Graduate School of Pharmaceutical Sciences, The University of Tokyo as a full professor. His research interests include the synthesis, design, and study of biologically important molecules, with particular emphasis on the total synthesis of structurally complex natural products. He has been honored with Novartis Chemistry Lectureship 2008/2009, the 5th JSPS Prize (2008), the Mukaiyama Award 2014, the Swiss Chemical Society Lectureship Award 2017/2018, and the 64th Synthetic Organic Chemistry Award, Japan (2022).
https://inoue.f.u-tokyo.ac.jp/e_index.html
Image

Prof. Dmitry Katayev, University of Bern (Switzerland)

Dmitry Katayev studied chemistry at D. I. Mendeleev Institute in Moscow and earned his PhD in Organic Chemistry from the group of Prof. Peter Künding at the University of Geneva (CH) in the end of 2012. Awarded by the Swiss National Science Foundation (SNSF) fellowship in 2013 he moved to the group of Prof. Lukas Gooßen at TU Kaiserslautern (DE) as a postdoctoral researcher. In 2015, he joined the group of Prof. Antonio Togni at ETH Zürich (CH) under SNSF return fellowship. He was later awarded the SNSF Ambizione grant and the Holcim Stiftung and started as a group leader at ETH Zürich in mid. of 2017. As a recipient of the SNSF Eccellenza Professorial Grant, he joined the University of Fribourg (CH) as an Assistant Professor in early 2021. Since October of 2022, he is an Assistant Professor with Tenure Track in Organic Chemistry at the University of Bern (CH). His research is focused on developing innovative catalytic strategies for molecular design that are driven by sustainable energy sources and utilize readily available functional group transfer reagents.

Image

Prof. Christof SparrUniversity of Basel (Switzerland)

Christof received his PhD from the ETH Zurich working in the group of Prof. Ryan Gilmour. He subsequently joined Prof. Dieter Seebach (ETH Zurich) and Prof. Steven V. Ley (University of Cambridge) as postdoctoral researcher. Christof then moved to the University of Basel and became habilitand mentored by Prof. Karl Gademann in 2013, Assistant Professor in 2016 and Associate Professor of Organic Chemistry in 2021. He is recipient of the ETH medal, a SNSF Starting Grant (equivalent to an ERC Starting Grant), the 2017 Werner Prize of the Swiss Chemical Society, the 2018 Ruzicka Prize of the ETH Zurich and an ERC Consolidator Grant.

https://chemie.unibas.ch/de/personen/christof-sparr/
Image

Prof. Peter Schreiner, Justus-Liebig University, Giessen (Germany)

Peter R. Schreiner is professor of organic chemistry and Liebig-Chair at the Institute of Organic Chemistry at the Justus Liebig University Giessen, Germany. He studied chemistry in his native city at the University of Erlangen-Nürnberg, Germany, where he received his Dr. rer. nat. (1994) in Organic Chemistry. Simultaneously, he obtained a PhD (1995) in Computational Chemistry from the University of Georgia, USA. He completed his habilitation (assistant professorship) at the University of Göttingen (1999), before becoming associate professor at the University of Georgia (Athens, USA), and head of the institute in Giessen in 2002. P. R. Schreiner is an elected member of the Leopoldina – German National Academy of Sciences, the North Rhine-Westphalian Academy of Sciences, Humanities, and the Arts, the Academy of Science and Literature (Mainz), the Berlin-Brandenburg Academy of Sciences, and is a Fellow of the Royal Society of Chemistry. He received the Dirac Medal (2003, WATOC), the Adolf-von-Baeyer Memorial Award of the German Chemical Society in 2017, the RSC Award in Physical Organic Chemistry of the RSC in 2019, the Academy Award of the Berlin-Brandenburg Academy of Science in 2020, and the ACS Arthur C. Cope Scholar Award 2021. He has been a visiting professor at the CNRS in Bordeaux, the Technion in Haifa, the Australian National University in Canberra, and the University of Florida in Gainesville. His research interests include organic reaction dynamics and reactive intermediates, quantum mechanical tunneling as well as London dispersion interactions as probed in the realm of nanodiamonds and organocatalysis. For more information visit
www.uni-giessen.de/schreiner
Image
Prof. David Niecewicz, University of North Carolina at Chapel Hilll (USA)
Dave Nicewicz completed his Ph.D. in 2006 at the University of North Carolina at Chapel Hill with Professor Jeffrey S. Johnson where he finished the total synthesis of Zaragozic Acid C. Nicewicz was then a Ruth L. Kirschstein Postdoctoral Fellow in the laboratories of the 2021 Chemistry Nobel Laureate, Professor David W. C. MacMillan. It was during this time that Nicewicz pioneered the use of ruthenium photoredox catalysis in combination with chiral amine organocatalysis to develop a general method for enantioselective aldehyde alkylation and more importantly, establishing photoredox catalysis as an emerging tool in organic synthesis. In 2009, Dave started as an Assistant Professor at the University of North Carolina at Chapel Hill. He was promoted to Associate Professor in 2015, full Professor in 2018 and was named the first Royce Murray Term Professor of Chemistry at UNC Chapel Hill in 2020. Dave’s research focuses on the use of organic photoredox catalysts to discover and invent new chemical reactivity. His work has garnered awards from industry such as the Boehringer Ingelheim New Investigator Award (2013), Eli Lilly Grantee (2015) as well as The Hirata Award (Nagoya University; 2017), and the ACS Cope Scholar Award (2022). In 2020, Nicewicz co-founded LED Radiofluidics with Prof. Zibo Li (UNC Radiology) to develop new automated radiolabeling modules and to design new radiotracers/radiotherapeutics.
 https://www.nicewiczlaboratory.com/
Image
Prof. Varinder Aggarwal, University of Bristol (UK)
Varinder K. Aggarwal studied chemistry at Cambridge University and received his Ph.D. in 1986 under the guidance of Dr. Stuart Warren. After postdoctoral studies (1986-1988) under Prof. Gilbert Stork, Columbia University, he returned to the UK as a Lecturer at Bath University. In 1991 he moved to Sheffield University, where he was promoted to Professor in 1997. In 2000 he moved to Bristol University where he holds the Chair in Synthetic Chemistry. He has received numerous awards including
RSC Perkin Award 2013; Gilbert Stork Lectureship at University of Wisconsin and Pennsylvania, 2016; Humboldt Research Award 2017; RSC Organic Synthesis Award 2017; Kurt Alder Lectureship 2018, Arthur C. Cope Award 2019, the Yamada-Koga Prize 2019, RS Davy Medal 2019, and the Xingda Lectureship Peking University, 2020. He
was elected Fellow of the Royal Society in 2012.
He has published >390 papers, 18 book chapters and 9 patents.
https://www.chm.bris.ac.uk/org/aggarwal/
Image
Prof. Tanja Gaich, University of Konstanz (Germany)
Tanja is a Professor of Organic Chemistry at the University of Konstanz (Germany) since 2015. After postdoctoral studies with Prof. P. S. Baran at the Scripps Research Institute in La Jolla (CA, USA), she took a position as an independent researcher at the Leibniz University Hannover. Tanja was born in Salzburg, where she studied molecular biology. In 1999 she transferred to Vienna to study chemistry, earning a PhD under the supervision of Prof. J. Mulzer in 2009. For her research she was awarded numerous prizes, including the Award of Excellence of the Austrian Ministry of Science and Education, the GÖCH-Dissertationspreis (Austrian Chemical Society), the LAUDIMAXIMA-Preis of the University of Vienna). In addition, she was awarded an Erwin-Schrödinger postdoctoral fellowship of Austrian Science Foundation. Her research is focused on total synthesis of complex natural products, including sarpagin, a Rauwolfia alkaloid, and taxol derivatives. She also searches for starting molecules that can serve for multiple total syntheses of natural products, taking the synthesis pathways in nature as her model.
https://www.chemie.uni-konstanz.de/gaich/team/prof-dr-tanja-gaich/

Industry Lectures

Image
Dr. Ana Maria Montagut
Dr. Ana Maria Montagut studied Chemistry at the Autonomous University of Barcelona and finished her degree at the Georg-August-Universität in Göttingen. Awarded by the Young Researchers Committee of Catalonia in 2013, by the VII International School of Organometallic Chemistry Marcial Moreno Mañas in 2014 and selected by Roche Continents among the 100 most talented students from all over Europe in 2016, in 2017 she obtained her PhD in Organic Chemistry at the Autonomous University of Barcelona in collaboration with the Heart Institute of the University of Ottawa, where she did a research stay. Ana Maria then started her industrial career as R&D Team Leader at Ferro. In 2020, she started a new role as a Postdoc/Project Manager in Medicinal Chemistry. Since 2022, she has been working as Senior Scientist for Arxada, developing new processes, evaluating new projects, and performing molecular modeling.
Image
Dr. Ulrich Mayerhöffer, Arxada
Dr. Ulrich Mayerhöffer studied Chemistry at the University of Würzburg and Heriot-Watt University Edinburgh. After finishing his dissertation in organic supramolecular chemistry at the University of Würzburg in 2011, he joined Lonza’s central R&D unit in Visp, Switzerland as a development chemist. He held different roles in chemical process development as well as production. In the course of the carve-out of Lonza’s chemical business he transitions to the newly formed Arxada AG in 2021 where he is leading the Technical Evaluation and Development team at Arxada’s largest production site in Visp, Switzerland.


Image
Dr. Marta Falcone, Valsynthese
Marta Falcone is an organic chemist by training, graduated with honors at the University of Pisa in 2011. She moved towards coordination chemistry for her PhD, at École polytechnique fédérale de Lausanne (EPFL), in the group of Prof. M. Mazzanti, working on small molecule activation by molecular uranium complexes. She was rewarded with the ISIC price (best doctoral thesis award in Chemistry and Chemical Engineering) for the contribution to fundamental chemistry and possible application in dinitrogen conversion, with several publications in important journals such as Nature and Nature Chemistry. After the PhD she won the grant from the Swiss National Science Foundation (SNSF) for young researchers and started a postdoc at Max Plank (Germany) in homogeneous catalysis. She has also been awarded from the Weizmann Institute (Israel) with Dimitris N. Chorafas Foundation Award for outstanding work in science. After few months she had the opportunity to start working in industry and left the academic path. Currently she works as a project leader in the R&D department of Valsynthese, the fine chemical division of SSE company, in Brig, Switzerland.
Image
Dr. Daniel Latassa, Valsynthese
As a Ph.D. student in the group of Prof. François Diederich at ETH-Zürich and coworker at Novartis’ Crop Protection, Dr. Daniel Latassa had the possibility to explore interdisciplinary fields such as heterogeneous catalysis, supramolecular chemistry, as well as solid phase synthesis in an inspiring and interactive working atmosphere. In 2004, after postdoctoral studies at the Université de Montréal with Prof. André B. Charette, and the Université de Fribourg with Prof. Christian Bochet, he accepted a position of project leader at Polyphor Ltd. In Allschwil. After two years of exciting chemistry, he moved to Lonza Ltd. in Visp, where he was a project leader in the field of peptides and oligonucleotides. Three years later, he took the opportunity to teach science in different schools during his Master studies at the Pedagogy College in St-Maurice. Since 2014, he has been working for Valsynthese, first as senior chemist in process development, and now as project manager.
Image

Ahmed Mahmoud, Chemspeed
Ahmed Mahmoud is a chemical engineer and material scientist by training with extensive experience in laboratory automation. He did his masters in 2014 the elite program of advanced materials and processes (MAP) and his research in the Max-Planck institute (MPI) for the science of light investigating the synthesis and application of gold and silver photonic nanostructures. He then did his PhD research at the University of Erlangen-Nürnberg in the institute of particle technology and worked on developing automation systems and high throughput synthesis and experimentation for advanced opto-electronic materials such as quantum dots and perovskites for display and solar cell applications. Ahmed worked afterwards in 2019 at Clariant GmbH in Frankfurt in the R&D sector, group technology and innovation (GTI) in the high throughput experimentation laboratory as an automation scientist working with a variety of robotic systems and platforms serving diverse business units within the corporation. He currently works as a workflow architect in the business unit material science and life science designing and translating workflows for different companies and organizations across the globe to automated solutions at Chemspeed Technologies, Füllinsdorf.

Image
Dr. Quentin Lefebvre, Spirochem
Quentin Lefebvre obtained his Master degree in physical sciences and chemistry in 2011 at the École Normale Supérieure de Lyon (France) as ‘élève normalien’. After a PhD at RWTH Aachen (Germany) with Prof. M. Rueping and a two-year postdoctoral stay at the University of Bristol (United Kingdom) with Prof. J. Clayden, he joined SpiroChem AG, a CRO in the field of Medicinal Chemistry based in Basel (Switzerland), in late 2018. He is now Team Leader, Project Leader, and R&D coordinator, working across several different projects in Medicinal Chemistry, while promoting and developing enabling technologies such as photoredox catalysis at SpiroChem. He was awarded a JSP Fellowship at the 2023 SCS Conference on Stereochemistry, ’Bürgenstock Conference’.

Career Session

Image
Lea Rumpf, Arxada
Lea Rumpf started her early career in the tourism industry and spent several months working and studying languages abroad during few years, before deciding to take another career path. She took on her first HR role in the telecommunications sector and completed various certifications in HR Management. After few years in different HR roles, Lea Rumpf moved to the chemical industry and joined Arxada in November 2021, in charge of establishing the new independent HR department and supporting various HR activities relating to the Carve-Out from Lonza. She is currently holding the position as HR Business Partner, managing the manufacturing site Visp and the center of excellence in Barcelona ad interim.
Image
Dr. Florent Beaufils, Spirochem
Florent has over 15 years of accomplishments in the Pharma/Biotech industry. His professional experience includes the discovery, process and preclinical development of various protein kinase inhibitors for the treatment of cancer (PQR309, FDA Orphan Drug Designation in 2016) and CNS disorders (PQR620), and a successful technology transfer (2009) with New England Biolabs (SNAP-tag®, CLIP-tag™).
Florent received his Ph.D. in Organic Chemistry with Prof. Philippe Renaud at the University of Bern in 2004 and carried out postdoctoral work on total synthesis with Prof. Alois Fürstner at the Max Planck Institute für Kohlenforschung in 2005. He was Head of Chemistry and Quality Control at Covalys Biosciences AG (Switzerland) (2005 - 2009), Senior Researcher at the Department of Biomedicine of the University of Basel (2009 - 2012) and Deputy Head of Chemistry at PIQUR Therapeutics AG (2012 - 2016).

Florent is co-author of numerous high impact scientific publications and co-inventor of 11 patents in the areas of drug discovery, process development and biological research.